JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged)
WKN A2PR30 | ISIN LU2053353665 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU0637847533 | Lacuna Global Health Plus I | +12,71 % | +11,58 % | 0,90 |
|
| 2 | LU0247050130 | Lacuna Global Health Plus P | +12,57 % | +11,59 % | 0,88 |
|
| 3 | LU0695506492 | BZ Fine Funds - BZ Fine Pharma A EUR | +11,09 % | +15,02 % | 0,58 |
|
| 4 | BE0170812920 | KBC Equity Fund Medical Technologies Classic | +6,33 % | +11,30 % | 0,36 |
|
| 5 | LU2036817042 | CPR Invest - MedTech - A EUR - Dist | +4,79 % | +12,82 % | 0,19 |
|
| 108 | IE00BNGJLK89 | Premium Selection UCITS ICAV - Polar Capital Future Healthcare Ah dis CHF | -13,04 % | +13,50 % | -1,14 |
|
| 109 | LU2053353749 | JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged) | -22,61 % | +21,39 % | -1,17 |
|
| 110 | LU2053353665 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | -23,02 % | +21,40 % | -1,18 |
|
| 111 | LU2314628723 | JPMorgan Funds - Thematics - Genetic Therapies C (dist) - GBP | -22,19 % | +19,67 % | -1,25 |
|
| 112 | LU2015349090 | Candriam Equities L Oncology, S-AH - Distribution | -12,89 % | +11,97 % | -1,27 |
|